Drug Shortage Report for CARBOPLATIN INJECTION BP
Report ID | 3295 |
Drug Identification Number | 02320371 |
Brand name | CARBOPLATIN INJECTION |
Common or Proper name | CARBOPLATIN |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | CARBOPLATIN |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 60 ML VIAL OF 600 MG | FLACON DE 60 ML DE 600 MG |
ATC code | L01XA |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-03-07 |
Actual start date | 2017-03-07 |
Estimated end date | 2017-04-05 |
Actual end date | 2017-03-31 |
Shortage status | Resolved |
Updated date | 2017-04-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-03-17 | English | Compare |
v2 | 2017-03-17 | French | Compare |
v3 | 2017-04-06 | English | Compare |
Showing 1 to 3 of 3